Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S O Yang

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Korean Medical Science|March 1, 1992
POEMS syndrome--a case reportJ W Kim, S K Lee, K M Ha, et al.
Clinical Nuclear Medicine|July 8, 2000
Use of Tc-99m HMPAO leukocyte scans to evaluate bone infection: incremental value of additional SPECT imagesY C Weon, S O Yang, Y Y Choi, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 1, 1993
Pulmonary paragonimiasis: clinical and experimental studiesJ G Im, Y Kong, Y M Shin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1992
Detection of extrapulmonary tuberculosis with gallium-67 scan and computed tomographyS O Yang, Y I Lee, D H Chung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 1997
Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjectsH J Kim, J H Im, S O Yang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2002
Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?Y Kim, J-M Kim, J-W Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 2006
An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized ratsM K Kim, H D Kim, J H Park, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Korean Medical Science|March 1, 1992
POEMS syndrome--a case reportJ W Kim, S K Lee, K M Ha, et al.
Clinical Nuclear Medicine|July 8, 2000
Use of Tc-99m HMPAO leukocyte scans to evaluate bone infection: incremental value of additional SPECT imagesY C Weon, S O Yang, Y Y Choi, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 1, 1993
Pulmonary paragonimiasis: clinical and experimental studiesJ G Im, Y Kong, Y M Shin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1992
Detection of extrapulmonary tuberculosis with gallium-67 scan and computed tomographyS O Yang, Y I Lee, D H Chung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 1997
Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjectsH J Kim, J H Im, S O Yang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2002
Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?Y Kim, J-M Kim, J-W Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 2006
An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized ratsM K Kim, H D Kim, J H Park, et al.
Pageof 3